AACE Annual Meeting 2024 On Demand

Starts 6/6/2024 | Expires 5/1/2024

Didn't make it to the AACE 2024 Annual Meeting? You can still access all the invaluable insights and groundbreaking discoveries with our on-demand session recordings. Gain newfound knowledge to improve patient outcomes, assess the potential applications of emerging scientific advances, and earn up to 49 CME/CE/MOC credits for eligible recorded sessions. Don't miss this opportunity to elevate your practice and professional growth—register now and experience the transformative content from AACE 2024 at your own pace.

Engaged Member: $539 | Informed Member: $719 | Non-member: $899



Learning Objectives

Upon successful completion of the program, participants should be better able to:   

  • Discuss the latest scientific and clinical discoveries in the field of endocrinology, diabetes, and metabolism. 
  • Apply newfound knowledge to diagnosis and management for improved patient outcomes. 
  • Assess the potential applications of emerging scientific advances that affect the practice of endocrinology. 
  • Empower participants to educate their patients regarding clinical treatment options. 
Target Audience

This activity is intended for medical professionals from the field of clinical endocrinology at all stages in their career including clinical endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, registered dietitians, medical students, residents, and fellows in training.

Accreditation and Designation Statements

Physicians and Physician Assistants 
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 49 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 49 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.  

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.

American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 49 contact hours.

Disclosures and Conflicts of Interest

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. 


Betul Hatipoglu, MD

Ineligible Company


Relevant Financial Relationship

Research Funding

Adriana Ioachimescu, MD, PhD, FACE

Ineligible Company

Xeris Pharmaceuticals
Recordati Rare Diseases

Relevant Financial Relationship

Research Funding; Consultant

Cecilia Low Wang, MD, FACE

Ineligible Company

Virta Health

Relevant Financial Relationship

Research Funding

Archana Sadhu, MD, FACE

Ineligible Company

Abbott Laboratories

Relevant Financial Relationship


Alex Tessnow, MD, ECNU, FACE

Ineligible Company

Horizon Pharmaceutical
Spectrix Therapeutics

Relevant Financial Relationship


All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.




None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.



Click to view faculty disclosures